150 related articles for article (PubMed ID: 27058846)
1. Emerging gene mutation targets in lung cancer.
Johnson BE
Clin Adv Hematol Oncol; 2015 Dec; 13(12):812-4. PubMed ID: 27058846
[No Abstract] [Full Text] [Related]
2. Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?
Keller JA; Erson-Bensan AE; Petty EM
Cancer Biol Ther; 2010 Nov; 10(9):942-4. PubMed ID: 21057211
[No Abstract] [Full Text] [Related]
3. New Targets in Non-Small Cell Lung Cancer.
Park SJ; More S; Murtuza A; Woodward BD; Husain H
Hematol Oncol Clin North Am; 2017 Feb; 31(1):113-129. PubMed ID: 27912827
[TBL] [Abstract][Full Text] [Related]
4. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
5. [Molecular pathology of lung cancer: key to personalized medicine].
Cheng L; Li Y; Zhang SB; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):715-20. PubMed ID: 23302321
[No Abstract] [Full Text] [Related]
6. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
7. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
Reck M; Rabe KF
N Engl J Med; 2017 Aug; 377(9):849-861. PubMed ID: 28854088
[No Abstract] [Full Text] [Related]
8. Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non-small cell lung cancer.
Peters MJ; Bowden JJ; Carpenter P; Lewis J; Solomon B
Intern Med J; 2014 Jun; 44(6):575-80. PubMed ID: 24720523
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene.
Bélanger MM; Roussel E; Couet J
Chest; 2004 May; 125(5 Suppl):106S. PubMed ID: 15136443
[No Abstract] [Full Text] [Related]
10. The role of third-generation epithelial growth factor receptor inhibitors in non-small cell lung cancer.
Sequist LV
Clin Adv Hematol Oncol; 2015 Mar; 13(3):147-9. PubMed ID: 26352419
[No Abstract] [Full Text] [Related]
11. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
Somaiah N; Simon NG; Simon GR
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
[No Abstract] [Full Text] [Related]
12. Invited commentary.
Korst RJ
Ann Thorac Surg; 2006 Jul; 82(1):248. PubMed ID: 16798223
[No Abstract] [Full Text] [Related]
13. Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
Zhang S; Sun Y
EBioMedicine; 2020 Apr; 54():102718. PubMed ID: 32268269
[No Abstract] [Full Text] [Related]
14. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
Somaiah N; Simon GR
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
[No Abstract] [Full Text] [Related]
15. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
16. Discovery of drug resistance biomarker could improve cancer treatment.
Pharmacogenomics; 2013 Jan; 14(2):125. PubMed ID: 23447824
[No Abstract] [Full Text] [Related]
17. [The progress of KIF5B-RET fusion gene in non-small cell lung cancer].
Jin LL; Kong H; Xie WP
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):524-6. PubMed ID: 24262090
[No Abstract] [Full Text] [Related]
18. EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation.
Koo DH; Kim KP; Choi CM; Lee DH; Lee JC; Lee JS; Jang SJ; Kim SW
Cancer Chemother Pharmacol; 2015 Jan; 75(1):197-206. PubMed ID: 25422153
[TBL] [Abstract][Full Text] [Related]
19. A Potential Epigenetic Therapy for NSCLC.
Cancer Discov; 2015 Apr; 5(4):341. PubMed ID: 25724377
[TBL] [Abstract][Full Text] [Related]
20. [Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance].
Cherfils-Vicini J; Damotte D; Fridman WH; Sautès-Fridman C; Cremer I
Med Sci (Paris); 2010 Apr; 26(4):435-7. PubMed ID: 20412752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
